Cited by 1,015PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 237 of the 241 references it cites were found in a registry or an index.

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Magnuson, Brian, Ekim, Bilgen, Fingar, Diane C.·2012·Biochemical Journal

DOI 10.1042/bj20110892

Open this paper in CoChat — free account

Abstract

The ribosomal protein S6K (S6 kinase) represents an extensively studied effector of the TORC1 [TOR (target of rapamycin) complex 1], which possesses important yet incompletely defined roles in cellular and organismal physiology. TORC1 functions as an environmental sensor by integrating signals derived from diverse environmental cues to promote anabolic and inhibit catabolic cellular functions. mTORC1 (mammalian TORC1) phosphorylates and activates S6K1 and S6K2, whose first identified substrate was rpS6 (ribosomal protein S6), a component of the 40S ribosome. Studies over the past decade have uncovered a number of additional S6K1 substrates, revealing multiple levels at which the mTORC1–S6K1 axis regulates cell physiology. The results thus far indicate that the mTORC1–S6K1 axis controls fundamental cellular processes, including transcription, translation, protein and lipid synthesis, cell growth/size and cell metabolism. In the present review we summarize the regulation of S6Ks, their cellular substrates and functions, and their integration within rapidly expanding mTOR (mammalian TOR) signalling networks. Although our understanding of the role of mTORC1–S6K1 signalling in physiology remains in its infancy, evidence indicates that this signalling axis controls, at least in part, glucose homoeostasis, insulin sensitivity, adipocyte metabolism, body mass and energy balance, tissue and organ size, learning, memory and aging. As dysregulation of this signalling axis contributes to diverse disease states, improved understanding of S6K regulation and function within mTOR signalling networks may enable the development of novel therapeutics.

Integrity signals

Registry

Crossref · 10.1042/bj20110892

Cites

237 of 237 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Collapse: how societies choose to fail or succeed
Lee, V. (2005) · Choice Reviews Online · doi:10.5860/choice.43-1028 · Cited by 3,081
mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773

Flagged first, then by citations

Show all 241 references

4 of the 241 references couldn’t be matched to a known paper.

Sorted by citations

The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Marrero, M. C., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,018
mTORC1 signaling and the metabolic control of cell growth
Ben‐Sahra, I., & Manning, B. D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.012 · Cited by 668
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Marçais, A., Cherfils‐Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2936 · Cited by 643
Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
Lin, J., Fallahi‐Sichani, M., & Sorger, P. K. (2015) · Nature Communications · doi:10.1038/ncomms9390 · Cited by 562
UPRmt regulation and output: a stress response mediated by mitochondrial-nuclear communication
Melber, A., & Haynes, C. M. (2018) · Cell Research · doi:10.1038/cr.2018.16 · Cited by 498
mTOR substrate phosphorylation in growth control
Battaglioni, S., Benjamin, D., Wälchli, M., Maier, T., & Hall, M. N. (2022) · Cell · doi:10.1016/j.cell.2022.04.013 · Cited by 443
Multiple Roles of the Small GTPase Rab7
Guerra, F., & Bucci, C. (2016) · Cells · doi:10.3390/cells5030034 · Cited by 414
Signaling Pathways Involved in the Regulation of mRNA Translation
Roux, P. P., & Topisirović, I. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00070-18 · Cited by 332
Cellular metabolic and autophagic pathways: Traffic control by redox signaling
Dodson, M. B., Darley-Usmar, V. M., & Zhang, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.014 · Cited by 333
Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316
Growing knowledge of the mTOR signaling network
Huang, K., & Fingar, D. C. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.09.011 · Cited by 310
Self-citation
mTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction
Igarashi, M., & Guarente, L. (2016) · Cell · doi:10.1016/j.cell.2016.05.044 · Cited by 305
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
Boudreau, A., Purkey, H. E., Hitz, A., Robarge, K., Peterson, D., Labadie, S., Kwong, M., Hong, R., Gao, M., Del Nagro, C., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2143 · Cited by 280
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
Jain, M. V., Paczulla, A., Klonisch, T. C., Dimgba, F. N., Rao, S. B., Roberg, K. B., Schweizer, F., Lengerke, C., Davoodpour, P., Palicharla, V. R., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12001 · Cited by 248
The S6K protein family in health and disease
Tavares, M. R., Pavan, I. C. B., do Amaral, C. L., Meneguello, L., Luchessi, A. D., & Simabuco, F. M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.001 · Cited by 252
The unique biology of germinal center B cells
Young, C., & Brink, R. A. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.015 · Cited by 243
Abnormal mTOR Activation in Autism
Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 232
AMPK directly activates mTORC2 to promote cell survival during acute energetic stress
Kazyken, D., Magnuson, B., Bodur, Ç., Acosta-Jaquez, H. A., Zhang, D., Tong, X., Barnes, T. M., Steinl, G. K., Patterson, N., Altheim, C. H., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3249 · Cited by 226
Self-citation
Akt and mTOR in B Cell Activation and Differentiation
Limon, J. J., & Fruman, D. A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00228 · Cited by 234
Redox control of skeletal muscle atrophy.
Powers, S. K., Morton, A. B., Ahn, B., & Smuder, A. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.021 · Cited by 207
The Translational Regulation in mTOR Pathway
Yang, M., Lu, Y., Piao, W., & Jin, H. (2022) · Biomolecules · doi:10.3390/biom12060802 · Cited by 217
Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus
Zhao, C., Yang, C., Wai, S. T. C., Zhang, Y., P. Portillo, M., Paoli, P., Wu, Y., San Cheang, W., Liu, B., Carpéné, C., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1501658 · Cited by 199
Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise
Brook, M. S., Wilkinson, D. J., Phillips, B. E., Pérez‐Schindler, J., Philp, A., Smith, K., & Atherton, P. J. (2015) · Acta Physiologica · doi:10.1111/apha.12532 · Cited by 214
Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
Tan, H. W. S., Sim, A. Y. L., & Long, Y. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00369-y · Cited by 205
Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167
The Hallmarks of Flavonoids in Cancer
Ponte, L. G. S., Pavan, I. C. B., Mancini, M. C. S., da Silva, L. G. S., Morelli, A. P., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2021) · Molecules · doi:10.3390/molecules26072029 · Cited by 188
The expanding role of mTOR in cancer cell growth and proliferation
Cargnello, M., Tcherkezian, J., & Roux, P. P. (2015) · Mutagenesis · doi:10.1093/mutage/geu045 · Cited by 172
Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes
Chen, J., Torcia, S., Xie, F., Lin, C.-J., Çakmak, H., Franciosi, F., Horner, K., Onodera, C. S., Song, J. S., Cedars, M. I., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2873 · Cited by 167
The Role of Diacylglycerol Kinase ζ and Phosphatidic Acid in the Mechanical Activation of Mammalian Target of Rapamycin (mTOR) Signaling and Skeletal Muscle Hypertrophy
You, J.-S., Lincoln, H. C., Kim, C.-R., Frey, J. W., Goodman, C. A., Zhong, X.-P., & Hornberger, T. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.531392 · Cited by 163
Signaling and Regulation of the Mitochondrial Unfolded Protein ResponsePreprint
Naresh, N. U., & Haynes, C. M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033944 · Cited by 166
The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration
Liu, Y., Miao, L., Liang, F., Huang, H., Teng, X., Li, S., Nuriddinov, J., Selzer, M. E., & Hu, Y. (2014) · Nature Communications · doi:10.1038/ncomms6416 · Cited by 168
AGC kinases, mechanisms of regulation and innovative drug development
Leroux, A. E., Schulze, J. O., & Biondi, R. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.011 · Cited by 164
TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging
Blackwell, T. K., Sewell, A. K., Wu, Z., & Han, M. (2019) · Genetics · doi:10.1534/genetics.119.302504 · Cited by 148
mTOR function and therapeutic targeting in breast cancer.
Hare, S. H., & Harvey, A. (2017) · PubMed Central · Cited by 150
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
Zhou, L., Xie, Y., Li, S., Liang, Y., Qiu, Q., Lin, H., & Zhang, Q. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0350-3 · Cited by 149
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126091 · Cited by 147
Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
Pérez-Revuelta, B. I., Hettich, M. M., Ciociaro, A., Rotermund, C., Kahle, P. J., Krauss, S., & Di Monte, D. A. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.175 · Cited by 140
Direct effects of airborne PM2.5 exposure on macrophage polarizations
Zhao, Q., Chen, H., Yang, T., Rui, W., Liu, F., Zhang, F., Zhao, Y. X., & Ding, W. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.033 · Cited by 145
Fasting enhances cold resistance in fish through stimulating lipid catabolism and autophagy
Lu, D., Ma, Q., Wang, J., Li, L., Han, S., Limbu, S. M., Li, D., Chen, L., Zhang, M., & Du, Z. (2019) · The Journal of Physiology · doi:10.1113/jp277091 · Cited by 148
Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects
Cai, H., Dong, L., & Liu, F. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.011 · Cited by 152
Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and Aging-Related Diseases via Anti-Oxidation and AMPK Activation
Xu, Z., Feng, W., Shen, Q., Yu, N., Yu, K., Wang, S., Chen, Z., Shioda, S., & Guo, Y. (2017) · Aging and Disease · doi:10.14336/ad.2016.0620 · Cited by 148
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma
Corcoran, R. B., Rothenberg, S. M., Hata, A. N., Faber, A. C., Piris, A., Nazarian, R. M., Brown, R. D., Godfrey, J. T., Winokur, D., Walsh, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005753 · Cited by 140
LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation
Zhou, C., Huang, C., Wang, J., Huang, H., Li, J., Xie, Q., Liu, Y., Zhu, J., Li, Y., Zhang, D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.14 · Cited by 139
A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis
Sharma, G., Guardia, C. M. A., Roy, A., Vassilev, A. P., Sarić, A., Griner, L. N., Marugán, J., Ferrer, M., Bonifacino, J. S., & Depamphilis, M. (2019) · Autophagy · doi:10.1080/15548627.2019.1586257 · Cited by 136
Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours
Wu, Z. R., Yan, L., Liu, Y. T., Cao, L., Guo, Y., Zhang, Y., Yao, H., Cai, L., Shang, H. B., Rui, W. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06853-3 · Cited by 135
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies
Liu, D., Wang, S., Liu, S., Wang, Q., Che, X., & Wu, G. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101270 · Cited by 157
EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice
Arif, A., Terenzi, F., Potdar, A. A., Jia, J., Sacks, J., China, A., Halawani, D., Vasu, K., Li, X., Brown, J. M., et al. (2017) · Nature · doi:10.1038/nature21380 · Cited by 128
Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy
Jordan, T. X., & Randall, G. C. (2017) · Journal of Virology · doi:10.1128/jvi.02020-16 · Cited by 135
CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation
Shuda, M., Velásquez, C., Cheng, E., Cordek, D. G., Kwun, H. J., Chang, Y., & Moore, P. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505787112 · Cited by 131
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
Guichard, S. M., Curwen, J., Bihani, T., D’Cruz, C. M., Yates, J. W. T., Grondine, M. R., Howard, Z., Davies, B. R., Bigley, G., Klinowska, T. C. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0365 · Cited by 133
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
Zeng, Z., Shi, Y. X., Tsao, T., Qiu, Y., Kornblau, S. M., Baggerly, K., Liu, W., Jessen, K., Liu, Y., Kantarjian, H. M., et al. (2012) · Blood · doi:10.1182/blood-2011-11-393934 · Cited by 128
Grb10 Promotes Lipolysis and Thermogenesis by Phosphorylation-Dependent Feedback Inhibition of mTORC1
Liu, M., Bai, J., He, S., Villarreal, R., Hu, D., Zhang, C., Yang, X., Liang, H., Slaga, T. J., Yu, Y., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.018 · Cited by 128
Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cells
Mutschelknaus, L., Azimzadeh, O., Heider, T., Winkler, K., Vetter, M. H. F., Kell, R., Tapio, S., Merl‐Pham, J., Huber, S. M., Edalat, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12403-6 · Cited by 125
tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase
Zuko, A., Mallik, M., Thompson, R., Spaulding, E. L., Wienand, A., Been, M., Tadenev, A. L. D., van Bakel, N. H. M., Sijlmans, C., Santos, L. A., et al. (2021) · Science · doi:10.1126/science.abb3356 · Cited by 124
Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance
Bond, P. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0118-y · Cited by 121
USP1 deubiquitinates Akt to inhibit PI3K‐Akt‐FoxO signaling in muscle during prolonged starvation
Goldbraikh, D., Neufeld, D., Eid‐Mutlak, Y., Lasry, I., Gilda, J. E., Parnis, A., & Cohen, S. (2020) · EMBO Reports · doi:10.15252/embr.201948791 · Cited by 126
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Cervantes-Madrid, D., Romero, Y., & Dueñas‐González, A. (2015) · BioMed Research International · doi:10.1155/2015/690492 · Cited by 125
Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs
Patwardhan, P. P., Surriga, O., Beckman, M. J., de Stanchina, E., DeMatteo, R. P., Tap, W. D., & Schwartz, G. K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2576 · Cited by 118
mTOR inhibitors and diabetes
Vergès, B. L., & Cariou, B. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.014 · Cited by 121
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications
Simone, V. D., d’Avenia, M., Argentiero, A., Felici, C., Rizzo, F. M., Pergola, G. D., & Silvestris, F. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0351 · Cited by 123
Eukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 127
Exploiting the yeast stress-activated signaling network to inform on stress biology and disease signaling
Ho, Y., & Gasch, A. P. (2015) · Current Genetics · doi:10.1007/s00294-015-0491-0 · Cited by 110
The Enigma of Rapamycin Dosage
Mukhopadhyay, S., Frías, M. A., Chatterjee, A., Yellen, P., & Foster, D. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0720 · Cited by 116
An overview of rapamycin: from discovery to future perspectives
Yoo, Y. J., Kim, H., Park, S. R., & Yoon, Y. J. (2016) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1834-7 · Cited by 114
Mitochondrial unfolded protein response: An emerging pathway in human diseases
Zhu, L., Zhou, Q., He, L., & Chen, L. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.013 · Cited by 118
Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling
Adhikari, D., Risal, S., Liu, K., & Shen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053810 · Cited by 108
The impact of tumor stroma on drug response in breast cancer
Dittmer, J., & Leyh, B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.05.006 · Cited by 107
The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation
Bjedov, I., & Rallis, C. (2020) · Genes · doi:10.3390/genes11091043 · Cited by 108
Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways
Wang, W., Dong, X., Liu, Y., Ni, B., Sai, N., You, L., Sun, M., Yao, Y., Qu, C., Yin, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110661 · Cited by 106
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease
Caccamo, A., Branca, C., Talboom, J. S., Shaw, D. M., Turner, D., Ma, L., Messina, A. A., Huang, Z., Wu, J., & Oddo, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2781-15.2015 · Cited by 105
Tissue‐specific insulin signaling in the regulation of metabolism and aging
Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 105
HDAC1 and HDAC2 Restrain the Intestinal Inflammatory Response by Regulating Intestinal Epithelial Cell Differentiation
Turgeon, N., Blais, M., Gagné, J. M., Tardif, V., Boudreau, F., Perreault, N., & Asselin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073785 · Cited by 105
TORC1 Promotes Phosphorylation of Ribosomal Protein S6 via the AGC Kinase Ypk3 in Saccharomyces cerevisiae
González, A., Shimobayashi, M., Eisenberg, T., Merle, D. A., Pendl, T., Hall, M. N., & Moustafa, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120250 · Cited by 103
mTORC1 signaling and IL‐17 expression: Defining pathways and possible therapeutic targets
Ren, W., Yin, J., Duan, J., Liu, G., Tan, B., Yang, G., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2015) · European Journal of Immunology · doi:10.1002/eji.201545886 · Cited by 102
The IKK‐related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists
Bodur, Ç., Kazyken, D., Huang, K., Üstünel, B. E., Siroky, K. A., Tooley, A. S., Gonzalez, I. E., Foley, D. H., Acosta-Jaquez, H. A., Barnes, T. M., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696164 · Cited by 100
Self-citation
Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c‐Jun pathway in adaptive resistance to drug‐induced apoptosis
Fallahi‐Sichani, M., Moerke, N. J., Niepel, M., Zhang, T., Gray, N. S., & Sorger, P. K. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145877 · Cited by 99
Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation
Hong, S., Zhao, B., Lombard, D. B., Fingar, D. C., & Inoki, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520734 · Cited by 101
Self-citation
Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling
Gao, S., Duan, C., Gao, G., Wang, X., & Yang, H. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.006 · Cited by 98
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity
Dutta, D., Xu, J., Dirain, M. L. S., & Leeuwenburgh, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.011 · Cited by 99
Quantitative Phosphoproteomics Reveals Pathways for Coordination of Cell Growth and Division by the Conserved Fission Yeast Kinase Pom1*
Kettenbach, A. N., Deng, L., Wu, Y., Baldissard, S., Adamo, M. E., Gerber, S. A., & Moseley, J. B. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045245 · Cited by 98
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
Morandi, F., Morandi, B., Horenstein, A. L., Chillemi, A., Quarona, V., Zaccarello, G., Carrega, P., Ferlazzo, G., Mingari, M. C., Moretta, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4693 · Cited by 96
p70 Ribosomal protein S6 kinase ( Rps6kb1 ): an update
Bahrami-B, F., Ataie-Kachoie, P., Pourgholami, M. H., & Morris, D. L. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202560 · Cited by 101
Status of mTOR Activity May Phenotypically Differentiate Senescence and Quiescence
Cho, S., & Hwang, E. S. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0042-1 · Cited by 106
Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling
Halicka, H. D., Zhao, H. L., Li, J., Lee, Y., Hsieh, T., WU, J. M., & Darżynkiewicz, Z. (2012) · Aging · doi:10.18632/aging.100521 · Cited by 96
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Mahoney, S. J., Narayan, S., Molz, L., Berstler, L. A., Kang, S. A., Vlasuk, G. P., & Saiah, E. (2018) · Nature Communications · doi:10.1038/s41467-018-03035-z · Cited by 88
Salmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae
Gjessing, M. C., Yutin, N., Tengs, T., Senkevich, T. G., Koonin, E. V., Rønning, H. P., Alarcón, M., Ylving, S., Lie, K. I., Saure, B., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01174-15 · Cited by 95
The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury
Al‐Ali, H., Ding, Y., Slepak, T. I., Wu, W., Sun, Y., Martinez‐Ondaro, Y., Xu, X., Lemmon, V., & Bixby, J. L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0931-17.2017 · Cited by 91
MAPK3/1 participates in the activation of primordial follicles through mTORC1‐KITL signaling
Zhao, Y., Zhang, Y., Li, J., Zheng, N., Xu, X., Yang, J., Xia, G., & Zhang, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25868 · Cited by 94
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity
Bonifacio, A., Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.010 · Cited by 93
Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressorPreprint
Kobayashi, M., Wilson, A. C., Chao, M. V., & Mohr, I. (2012) · Genes & Development · doi:10.1101/gad.190157.112 · Cited by 95
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
Järås, M., Miller, P. G., Chu, L. P., Puram, R. V., Fink, E. C., Schneider, R. K., Al-Shahrour, F., Peña, P., Breyfogle, L. J., Hartwell, K. A., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131033 · Cited by 92
Translation factors and ribosomal proteins control tumor onset and progression: how?
Loreni, F., Mancino, M., & Biffo, S. (2013) · Oncogene · doi:10.1038/onc.2013.153 · Cited by 91
PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
Chen, Q. Y., & Costa, M. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112268 · Cited by 92
Ras drives malignancy through stem cell crosstalk with the microenvironment
Yuan, S., Stewart, K. S., Yang, Y., Abdusselamoglu, M. D., Parigi, S. M., Feinberg, T. Y., Tumaneng, K., Yang, H., Levorse, J. M., Polak, L., et al. (2022) · Nature · doi:10.1038/s41586-022-05475-6 · Cited by 91
Intramuscular Anabolic Signaling and Endocrine Response Following Resistance Exercise: Implications for Muscle Hypertrophy
Gonzalez, A. M., Hoffman, J. R., Stout, J. R., Fukuda, D. H., & Willoughby, D. S. (2015) · Sports Medicine · doi:10.1007/s40279-015-0450-4 · Cited by 97
mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19
Ramaiah, M. J. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100765 · Cited by 90
Beyond controlling cell size: functional analyses of S6K in tumorigenesis
Wu, X., Xie, W., Xie, W., Wei, W., & Guo, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05081-4 · Cited by 96

Authors: Magnuson, B., Ekim, B., & Fingar, D. C.
Affiliations: University of Michigan (US)
Department of Cell and Developmental Biology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, U.S.A.
Corresponding author: Magnuson, Brian
ORCID: Magnuson, Brian
Fingar, Diane C.
Venue: Biochemical Journal
Publisher: Portland Press Ltd.
Published: 2011-12-14
Volume: 441
Issue: 1
Pages: 1-21
ISSN: 0264-6021 (ISSN-L)
1470-8728
DOI: 10.1042/bj20110892
OpenAlex: W2312282875
Cited by: 1,015
References: 241
Citations by year: 2026: 52 · 2025: 57 · 2024: 63 · 2023: 67 · 2022: 57 · 2021: 72 · 2020: 69 · 2019: 82 · 2018: 87 · 2017: 85 · 2016: 73 · 2015: 84 · 2014: 68 · 2013: 64 · 2012: 34
FWCI: 4.89
Type: journal article
Language: en
Open access: closed
Locations: Biochemical Journal (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01dk078135-03)
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-078135, R01DK100722)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords: S6K, S6K1, S6K2, mTORC1, TOR signaling, ribosomal protein S6, translational regulation, glucose homeostasis, insulin sensitivity, adipocyte metabolism, energy balance, organ size, learning and memory, aging, disease therapeutics
MeSH terms: Animals, Gene Expression Regulation, Humans, Signal Transduction, Ribosomal Protein S6 Kinases, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks